Corrigendum to “RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin” [J. Funct. Foods (2015) 19PA (236–247)] (S1756464615004478)(10.1016/j.jff.2015.09.030);RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin

Journal of Functional Foods

Volumn 19, Issue , 2015, Pages 236-247

  Lin, Cheng Wei ^a,b   Lai, Gi Ming ^c   Chen, Ku Chung ^a,b   Lin, Tsung Han ^d   Fan, Jhen Jia ^d   Hsu, Rhu Long ^a,b   Chou, Chih Ming ^a,b   Lin, Chun Mao ^a,b   Kandaswami, Chithan C ^d   Lee, Ming Ting ^e   Cheng, Chia Hsiung ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Castle Hills Health   (India)

^e INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

10058 F4; Agarose; C Myc; Cervical cancer; DMSO; Invasiveness; Luteolin; LY294002; MTT; Quercetin; Rapamycin; RPS12

Indexed keywords

EID: 84946403888     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.12.018     Document Type: Erratum

References (39)

1. Adhami V.M., Syed D.N., Khan N., Mukhtar H. Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. Biochemical Pharmacology 2012, 84(10):1277-1281.
2. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochemical Pharmacology 1997, 53(11):1649-1657.
3. Boon K., Caron H.N., van Asperen R., Valentijn L., Hermus M.C., van Sluis P., Roobeek I., Weis I., Voute P.A., Schwab M., Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. The EMBO Journal 2001, 20(6):1383-1393.
4. Brogna S., Sato T.A., Rosbash M. Ribosome components are associated with sites of transcription. Molecular Cell 2002, 10(1):93-104.
5. Chen D., Zhang R., Shen W., Fu H., Liu S., Sun K., Sun X. RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector. International Journal of Oncology 2013, 42(5):1763-1769.
6. Chen F.W., Ioannou Y.A. Ribosomal proteins in cell proliferation and apoptosis. International Reviews of Immunology 1999, 18(5-6):429-448.
7. Cheng C.H., Chen G.D., Yeh M.S., Chu C.Y., Hsu Y.L., Hwang P.P., Huang F.L., Huang C.J. Expression and characterization of the JAK kinase and STAT protein from brine shrimp, Artemia franciscana. Fish and Shellfish Immunology 2010, 28(5-6):774-782.
8. Cheng Q., Lau W.M., Chew S.H., Ho T.H., Tay S.K., Hui K.M. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. British Journal of Cancer 2002, 86(2):274-281.
9. Dai M.S., Arnold H., Sun X.X., Sears R., Lu H. Inhibition of c-Myc activity by ribosomal protein L11. The EMBO Journal 2007, 26(14):3332-3345.
10. Dang C.V., O'Donnell K.A., Zeller K.I., Nguyen T., Osthus R.C., Li F. The c-Myc target gene network. Seminars in Cancer Biology 2006, 16(4):253-264.
11. Deng S.S., Xing T.Y., Zhou H.Y., Xiong R.H., Lu Y.G., Wen B., Liu S.Q., Yang H.J. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics, Proteomics and Bioinformatics 2006, 4(3):165-172.
12. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annual Review of Cell and Developmental Biology 2000, 16:653-699.
13. Guo Q.M., Malek R.L., Kim S., Chiao C., He M., Ruffy M., Sanka K., Lee N.H., Dang C.V., Liu E.T. Identification of c-myc responsive genes using rat cDNA microarray. Cancer Research 2000, 60(21):5922-5928.
14. Hasebe Y., Egawa K., Yamazaki Y., Kunimoto S., Hirai Y., Ida Y., Nose K. Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biological and Pharmaceutical Bulletin 2003, 26(10):1379-1383.
15. Huang Y.T., Hwang J.J., Lee P.P., Ke F.C., Huang J.H., Huang C.J., Kandaswami C., Middleton E., Lee M.T. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. British Journal of Pharmacology 1999, 128(5):999-1010.
16. Kao W.T., Lin C.Y., Lee L.T., Lee P.P., Hung C.C., Lin Y.S., Chen S.H., Ke F.C., Hwang J.J., Lee M.T. Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a Boyden chamber assay. Anticancer Research 2008, 28(4B):2109-2120.
17. Kobayashi T., Sasaki Y., Oshima Y., Yamamoto H., Mita H., Suzuki H., Toyota M., Tokino T., Itoh F., Imai K., Shinomura Y. Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. International Journal of Molecular Medicine 2006, 18(1):161-170.
18. Kondoh N., Shuda M., Tanaka K., Wakatsuki T., Hada A., Yamamoto M. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Research 2001, 21(4A):2429-2433.
19. Lin C.Y., Tsai P.H., Kandaswami C.C., Chang G.D., Cheng C.H., Huang C.J., Lee P.P., Hwang J.J., Lee M.T. Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells. Molecular Cancer 2011, 10:87.
20. Lin Y.S., Tsai P.H., Kandaswami C.C., Cheng C.H., Ke F.C., Lee P.P., Hwang J.J., Lee M.T. Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells. Cancer Science 2011, 102(10):1829-1839.
21. Lin C.Y., Tsai P.H., Kandaswami C.C., Lee P.P., Huang C.J., Hwang J.J., Lee M.T. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Science 2011, 102(4):815-827.
22. Lin Y.C., Tsai P.H., Lin C.Y., Cheng C.H., Lin T.H., Lee K.P., Huang K.Y., Chen S.H., Hwang J.J., Kandaswami C.C., Lee M.T. Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells. PLoS ONE 2013, 8(8):e71903.
23. Lu B., Xu J., Zhu Y., Zhang H., Lai M. Systemic analysis of the differential gene expression profile in a colonic adenoma-normal SSH library. Clinica Chimica Acta 2007, 378(1-2):42-47.
24. Macias E., Jin A., Deisenroth C., Bhat K., Mao H., Lindstrom M.S., Zhang Y. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010, 18(3):231-243.
25. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews 2000, 52(4):673-751.
26. Pogue-Geile K., Geiser J.R., Shu M., Miller C., Wool I.G., Meisler A.I., Pipas J.M. Ribosomal protein genes are overexpressed in colorectal cancer: Isolation of a cDNA clone encoding the human S3 ribosomal protein. Molecular and Cellular Biology 1991, 11(8):3842-3849.
27. Qiao M., Sheng S., Pardee A.B. Metastasis and AKT activation. Cell Cycle (Georgetown, Tex.) 2008, 7(19):2991-2996.
28. Somanath P.R., Razorenova O.V., Chen J., Byzova T.V. Akt1 in endothelial cell and angiogenesis. Cell Cycle (Georgetown, Tex.) 2006, 5(5):512-518.
29. Sun X.J., Hao D.M., Zheng Z.H., Fu H., Xu H.M., Wang M.X., Sun K.L. [Screening and analysis of associated genes in the carcinogenesis and progression of gastric cancer]. Chinese Journal of Medical Genetics 2005, 22(1):31-34.
30. Sun X.J., Sun K.L., Zheng Z.H., Hao D.M., Fu W.N., Xu H.M., Chen J.Q., Li X.M. Analysis of gene expression profiles for distinct stages of intestinal-type gastric cancer using suppression subtractive hybridization and cDNA microarray. Scandinavian Journal of Gastroenterology 2005, 40(10):1244-1245.
31. Triantafyllou A., Mylonis I., Simos G., Bonanou S., Tsakalof A. Flavonoids induce HIF-1alpha but impair its nuclear accumulation and activity. Free Radical Biology and Medicine 2008, 44(4):657-670.
32. van Riggelen J., Yetil A., Felsher D.W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nature Reviews. Cancer 2010, 10(4):301-309.
33. Wang F., Kuang Y., Salem N., Anderson P.W., Lee Z. Cross-species hybridization of woodchuck hepatitis viral infection-induced woodchuck hepatocellular carcinoma using human, rat and mouse oligonucleotide microarrays. Journal of Gastroenterology and Hepatology 2009, 24(4):605-617.
34. Wang Q., Yang C., Zhou J., Wang X., Wu M., Liu Z. Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene 2001, 263(1-2):205-209.
35. Wu H., Jiang H., Lu D., Xiong Y., Qu C., Zhou D., Mahmood A., Chopp M. Effect of simvastatin on glioma cell proliferation, migration, and apoptosis. Neurosurgery 2009, 65(6):1087-1096. discussion 1096-1087.
36. Wu H., Lu D., Jiang H., Xiong Y., Qu C., Li B., Mahmood A., Zhou D., Chopp M. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. Journal of Neurotrauma 2008, 25(2):130-139.
37. Zhang L., Hou Y., Wu K., Li D. Comparative proteomics analysis of chronic atrophic gastritis: Changes of protein expression in chronic atrophic gastritis without Helicobacter pylori infection. Brazilian Journal of Medical and Biological Research 2012, 45(3):273-283.
38. Zhou F., Qu L., Lv K., Chen H., Liu J., Liu X., Li Y., Sun X. Luteolin protects against reactive oxygen species-mediated cell death induced by zinc toxicity via the PI3K-Akt-NF-kappaB-ERK-dependent pathway. Journal of Neuroscience Research 2011, 89(11):1859-1868.
39. Zhou X., Hao Q., Liao J.M., Liao P., Lu H. Ribosomal protein S14 negatively regulates c-Myc activity. The Journal of Biological Chemistry 2013, 288(30):21793-21801.